A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC)

A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I–IIIA non-small cell lung cancer after resection

“…We identified gender, drinking history, the ratio of CD4 + T/CD8 + T, along with TNM stage as independent factors for prediction via multivariate cox analysis. Most of these independent factors were consistent with a host of previous findings on risk factors for NSCLC (37)(38)(39). Subsequently, the above 4 predictors were integrated into a nomogram to calculate the risk probability of disease recurrence or metastasis tailored to each individual patient.…”